United States Erythropoietin Market Report 2017

January 2017 | 105 pages | ID: UE1C079D867EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Erythropoietin

Revenue, means the sales value of Erythropoietin

This report studies sales (consumption) of Erythropoietin in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Amgen Inc
• Johnson & Johnson
• Hospira Inc
• Roche
• LG Life Sciences Ltd
• Biocon
• Intas Pharmaceuticals
• Teva Pharmaceutical Industries Ltd
• Ranbaxy Laboratories Ltd., and
• Celltrion, Inc

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Epoetin-alfa
• Epoetin-beta
• Darbepoetin-alfa
• Others

Split by applications, this report focuses on sales, market share and growth rate of Erythropoietin in each application, can be divided into

• Anemia (Cancer and HIV treatment)
• Kidney Disorders (ESRD and Dialysis)
• Others (Neural Disease and Wound healing)

Contents

United States Erythropoietin Market Report 2017

1 ERYTHROPOIETIN OVERVIEW

1.1 Product Overview and Scope of Erythropoietin
1.2 Classification of Erythropoietin
  1.2.1 Epoetin-alfa
  1.2.2 Epoetin-beta
  1.2.3 Darbepoetin-alfa
  1.2.4 Others
1.3 Application of Erythropoietin
  1.3.1 Anemia (Cancer and HIV treatment)
  1.3.2 Kidney Disorders (ESRD and Dialysis)
  1.3.3 Others (Neural Disease and Wound healing)
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Erythropoietin (2011-2021)
  1.4.1 United States Erythropoietin Sales and Growth Rate (2011-2021)
  1.4.2 United States Erythropoietin Revenue and Growth Rate (2011-2021)

2 UNITED STATES ERYTHROPOIETIN COMPETITION BY MANUFACTURERS

2.1 United States Erythropoietin Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Erythropoietin Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Erythropoietin Average Price by Manufactures (2015 and 2016)
2.4 Erythropoietin Market Competitive Situation and Trends
  2.4.1 Erythropoietin Market Concentration Rate
  2.4.2 Erythropoietin Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES ERYTHROPOIETIN SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2011-2016)

3.1 United States Erythropoietin Sales and Market Share by States (2011-2016)
3.2 United States Erythropoietin Revenue and Market Share by States (2011-2016)
3.3 United States Erythropoietin Price by States (2011-2016)

4 UNITED STATES ERYTHROPOIETIN SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

4.1 United States Erythropoietin Sales and Market Share by Type (2011-2016)
4.2 United States Erythropoietin Revenue and Market Share by Type (2011-2016)
4.3 United States Erythropoietin Price by Type (2011-2016)
4.4 United States Erythropoietin Sales Growth Rate by Type (2011-2016)

5 UNITED STATES ERYTHROPOIETIN SALES (VOLUME) BY APPLICATION (2011-2016)

5.1 United States Erythropoietin Sales and Market Share by Application (2011-2016)
5.2 United States Erythropoietin Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 UNITED STATES ERYTHROPOIETIN MANUFACTURERS PROFILES/ANALYSIS

6.1 Amgen Inc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Erythropoietin Product Type, Application and Specification
    6.1.2.1 Epoetin-alfa
    6.1.2.2 Epoetin-beta
  6.1.3 Amgen Inc Erythropoietin Sales, Revenue, Price and Gross Margin (2011-2016)
  6.1.4 Main Business/Business Overview
6.2 Johnson & Johnson
  6.2.2 Erythropoietin Product Type, Application and Specification
    6.2.2.1 Epoetin-alfa
    6.2.2.2 Epoetin-beta
  6.2.3 Johnson & Johnson Erythropoietin Sales, Revenue, Price and Gross Margin (2011-2016)
  6.2.4 Main Business/Business Overview
6.3 Hospira Inc
  6.3.2 Erythropoietin Product Type, Application and Specification
    6.3.2.1 Epoetin-alfa
    6.3.2.2 Epoetin-beta
  6.3.3 Hospira Inc Erythropoietin Sales, Revenue, Price and Gross Margin (2011-2016)
  6.3.4 Main Business/Business Overview
6.4 Roche
  6.4.2 Erythropoietin Product Type, Application and Specification
    6.4.2.1 Epoetin-alfa
    6.4.2.2 Epoetin-beta
  6.4.3 Roche Erythropoietin Sales, Revenue, Price and Gross Margin (2011-2016)
  6.4.4 Main Business/Business Overview
6.5 LG Life Sciences Ltd
  6.5.2 Erythropoietin Product Type, Application and Specification
    6.5.2.1 Epoetin-alfa
    6.5.2.2 Epoetin-beta
  6.5.3 LG Life Sciences Ltd Erythropoietin Sales, Revenue, Price and Gross Margin (2011-2016)
  6.5.4 Main Business/Business Overview
6.6 Biocon
  6.6.2 Erythropoietin Product Type, Application and Specification
    6.6.2.1 Epoetin-alfa
    6.6.2.2 Epoetin-beta
  6.6.3 Biocon Erythropoietin Sales, Revenue, Price and Gross Margin (2011-2016)
  6.6.4 Main Business/Business Overview
6.7 Intas Pharmaceuticals
  6.7.2 Erythropoietin Product Type, Application and Specification
    6.7.2.1 Epoetin-alfa
    6.7.2.2 Epoetin-beta
  6.7.3 Intas Pharmaceuticals Erythropoietin Sales, Revenue, Price and Gross Margin (2011-2016)
  6.7.4 Main Business/Business Overview
6.8 Teva Pharmaceutical Industries Ltd
  6.8.2 Erythropoietin Product Type, Application and Specification
    6.8.2.1 Epoetin-alfa
    6.8.2.2 Epoetin-beta
  6.8.3 Teva Pharmaceutical Industries Ltd Erythropoietin Sales, Revenue, Price and Gross Margin (2011-2016)
  6.8.4 Main Business/Business Overview
6.9 Ranbaxy Laboratories Ltd., and
  6.9.2 Erythropoietin Product Type, Application and Specification
    6.9.2.1 Epoetin-alfa
    6.9.2.2 Epoetin-beta
  6.9.3 Ranbaxy Laboratories Ltd., and Erythropoietin Sales, Revenue, Price and Gross Margin (2011-2016)
  6.9.4 Main Business/Business Overview
6.10 Celltrion, Inc
  6.10.2 Erythropoietin Product Type, Application and Specification
    6.10.2.1 Epoetin-alfa
    6.10.2.2 Epoetin-beta
  6.10.3 Celltrion, Inc Erythropoietin Sales, Revenue, Price and Gross Margin (2011-2016)
  6.10.4 Main Business/Business Overview

7 ERYTHROPOIETIN MANUFACTURING COST ANALYSIS

7.1 Erythropoietin Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Erythropoietin

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Erythropoietin Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Erythropoietin Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ERYTHROPOIETIN MARKET FORECAST (2016-2021)

11.1 United States Erythropoietin Sales, Revenue Forecast (2016-2021)
11.2 United States Erythropoietin Sales Forecast by Type (2016-2021)
11.3 United States Erythropoietin Sales Forecast by Application (2016-2021)
11.4 Erythropoietin Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Erythropoietin
Table Classification of Erythropoietin
Figure United States Sales Market Share of Erythropoietin by Type in 2015
Figure Epoetin-alfa Picture
Figure Epoetin-beta Picture
Figure Darbepoetin-alfa Picture
Figure Others Picture
Table Application of Erythropoietin
Figure United States Sales Market Share of Erythropoietin by Application in 2015
Figure Anemia (Cancer and HIV treatment) Examples
Figure Kidney Disorders (ESRD and Dialysis) Examples
Figure Others (Neural Disease and Wound healing) Examples
Figure United States Erythropoietin Sales and Growth Rate (2011-2021)
Figure United States Erythropoietin Revenue and Growth Rate (2011-2021)
Table United States Erythropoietin Sales of Key Manufacturers (2015 and 2016)
Table United States Erythropoietin Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Erythropoietin Sales Share by Manufacturers
Figure 2016 Erythropoietin Sales Share by Manufacturers
Table United States Erythropoietin Revenue by Manufacturers (2015 and 2016)
Table United States Erythropoietin Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Erythropoietin Revenue Share by Manufacturers
Table 2016 United States Erythropoietin Revenue Share by Manufacturers
Table United States Market Erythropoietin Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Erythropoietin Average Price of Key Manufacturers in 2015
Figure Erythropoietin Market Share of Top 3 Manufacturers
Figure Erythropoietin Market Share of Top 5 Manufacturers
Table United States Erythropoietin Sales by States (2011-2016)
Table United States Erythropoietin Sales Share by States (2011-2016)
Figure United States Erythropoietin Sales Market Share by States in 2015
Table United States Erythropoietin Revenue and Market Share by States (2011-2016)
Table United States Erythropoietin Revenue Share by States (2011-2016)
Figure Revenue Market Share of Erythropoietin by States (2011-2016)
Table United States Erythropoietin Price by States (2011-2016)
Table United States Erythropoietin Sales by Type (2011-2016)
Table United States Erythropoietin Sales Share by Type (2011-2016)
Figure United States Erythropoietin Sales Market Share by Type in 2015
Table United States Erythropoietin Revenue and Market Share by Type (2011-2016)
Table United States Erythropoietin Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Erythropoietin by Type (2011-2016)
Table United States Erythropoietin Price by Type (2011-2016)
Figure United States Erythropoietin Sales Growth Rate by Type (2011-2016)
Table United States Erythropoietin Sales by Application (2011-2016)
Table United States Erythropoietin Sales Market Share by Application (2011-2016)
Figure United States Erythropoietin Sales Market Share by Application in 2015
Table United States Erythropoietin Sales Growth Rate by Application (2011-2016)
Figure United States Erythropoietin Sales Growth Rate by Application (2011-2016)
Table Amgen Inc Basic Information List
Table Amgen Inc Erythropoietin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Inc Erythropoietin Sales Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Erythropoietin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson Erythropoietin Sales Market Share (2011-2016)
Table Hospira Inc Basic Information List
Table Hospira Inc Erythropoietin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hospira Inc Erythropoietin Sales Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Erythropoietin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Erythropoietin Sales Market Share (2011-2016)
Table LG Life Sciences Ltd Basic Information List
Table LG Life Sciences Ltd Erythropoietin Sales, Revenue, Price and Gross Margin (2011-2016)
Table LG Life Sciences Ltd Erythropoietin Sales Market Share (2011-2016)
Table Biocon Basic Information List
Table Biocon Erythropoietin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biocon Erythropoietin Sales Market Share (2011-2016)
Table Intas Pharmaceuticals Basic Information List
Table Intas Pharmaceuticals Erythropoietin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Intas Pharmaceuticals Erythropoietin Sales Market Share (2011-2016)
Table Teva Pharmaceutical Industries Ltd Basic Information List
Table Teva Pharmaceutical Industries Ltd Erythropoietin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceutical Industries Ltd Erythropoietin Sales Market Share (2011-2016)
Table Ranbaxy Laboratories Ltd., and Basic Information List
Table Ranbaxy Laboratories Ltd., and Erythropoietin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ranbaxy Laboratories Ltd., and Erythropoietin Sales Market Share (2011-2016)
Table Celltrion, Inc Basic Information List
Table Celltrion, Inc Erythropoietin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Celltrion, Inc Erythropoietin Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Erythropoietin
Figure Manufacturing Process Analysis of Erythropoietin
Figure Erythropoietin Industrial Chain Analysis
Table Raw Materials Sources of Erythropoietin Major Manufacturers in 2015
Table Major Buyers of Erythropoietin
Table Distributors/Traders List
Figure United States Erythropoietin Production and Growth Rate Forecast (2016-2021)
Figure United States Erythropoietin Revenue and Growth Rate Forecast (2016-2021)
Table United States Erythropoietin Production Forecast by Type (2016-2021)
Table United States Erythropoietin Consumption Forecast by Application (2016-2021)
Table United States Erythropoietin Sales Forecast by States (2016-2021)
Table United States Erythropoietin Sales Share Forecast by States (2016-2021)